Somnomed | SOM - Selling And Administration Expenses

Stock Price
0.64
Daily Change
-0.03 -3.79%
Monthly
-9.93%
Yearly
15.45%
Q1 Forecast
0.65

Somnomed reported AUD19.5M in Selling and Administration Expenses for its fiscal semester ending in June of 2023.





Selling And Administration Expenses Change Date
Alcidion AUD 909K 12.94M Jun/2025
Cochlear AUD 449.4M 214.45M Dec/2025
Fisher & Paykel Healthcare NZD 285.5M 11.6M Dec/2025
Nanosonics AUD 53.78M 26.93M Dec/2025
Polynovo AUD 21.13M 18.27M Jun/2024
ResMed USD 275.7M 16.51M Dec/2025